The Effect of Mouthwash Containing Pomegranate Peel Extract and Chlorhexidine Mouthwash on Bleeding on Brushing

Sponsor
Cairo University (Other)
Overall Status
Unknown status
CT.gov ID
NCT02939092
Collaborator
(none)
60
2
1

Study Details

Study Description

Brief Summary

To evaluate the clinical effectiveness of mouthwash containing pomegranate peel extract and chlorhexidine mouthwash on bleeding on brushing and counting of streptococcus mutans among a group of Egyptian children with permanent dentition.

Condition or Disease Intervention/Treatment Phase
N/A

Detailed Description

To evaluate the clinical effectiveness of mouthwash containing pomegranate peel extract and chlorhexidine mouthwash on bleeding on brushing and counting of streptococcus mutans among a group of Egyptian children with permanent dentition.

PICO:

Population (P): Children with full permanent dentition. Intervention (I): Pomegranates peel extract. Comparator (C): Chlorhexidine.

Outcome(O):

Primary outcome: Bleeding on brushing, criteria:Asking patient, unit:Binary. Secondary outcome:Counting streptococcus mutans, criteria: Agar plate, unit: CFUs/mL

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
The Effect of Mouthwash Containing Pomegranate Peel Extract and Chlorhexidine Mouthwash on Bleeding on Brushing Among a Group of Egyptian Children With Full Permanent Dentition, Randomized Controlled Trial
Anticipated Study Start Date :
Jan 1, 2018
Anticipated Primary Completion Date :
Jan 1, 2018
Anticipated Study Completion Date :
Feb 1, 2018

Arms and Interventions

Arm Intervention/Treatment
Experimental: Pomegranate peel extract

Pomegranate is antimicrobial, anti inflammatory and antioxidant

Drug: Pomegranates peel extract
Pomegranate is antimicrobial

Active Comparator: Chlorhexidine

Chlorhexidine mouthwash is antiplaque treatment and effective against gingivitis

Drug: Chlorhexidine
Chlorhexidine mouthwash is antiplaque agent

Outcome Measures

Primary Outcome Measures

  1. Bleeding on brushing, Measurement: asking patient , Unit: Binary [2 weeks]

Secondary Outcome Measures

  1. Counting streptococcus mutans, Measurement: Agar plate, Unit: CFUs/mL [2 weeks]

Eligibility Criteria

Criteria

Ages Eligible for Study:
12 Years to 15 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • children aged 12-15 years old.

  • Cooperative children.

  • Both genders.

  • Medically free.

Exclusion Criteria:
  • Children undergoing orthodontic treatment.

  • Children using any other oral hygiene aid other than routine teeth brushing.

  • Children with known history of allergy to any mouth rinse or drug.

  • Parents unable to give informed consent.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Cairo University

Investigators

  • Study Director: Salah El Behery, Professor, Cairo University

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

Responsible Party:
Heba Moahmed Fouad, Principle investigator, Cairo University
ClinicalTrials.gov Identifier:
NCT02939092
Other Study ID Numbers:
  • CairoE
First Posted:
Oct 19, 2016
Last Update Posted:
Jan 24, 2018
Last Verified:
Jan 1, 2018
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Heba Moahmed Fouad, Principle investigator, Cairo University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 24, 2018